1.	Early Detection of Prostate Cancer by FACS Phase: Phase IV Type: Diagnostic Status: Active Age: 60 to 90 Sponsor: Other Protocol IDs: HP 7-251 S, NCT00524823
2.	Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer Phase: Phase IV Type: Supportive care Status: Active Age: 40 to 69 Sponsor: Other Protocol IDs: STAF001982HU, NCT00906269
3.	3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer Phase: Phase IV Type: Prevention Status: Active Age: 55 and over Sponsor: NCI, Other Protocol IDs: ROI10-352, R01CA138627, NCT01296672
4.	Stereotactic Body Radiotherapy for Prostate Cancer Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-022, NCT01352598
5.	Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy Phase: Phase IV Type: Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: Thin-1, NCT01379742
6.	Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: IRB# 11-002288, NCT01365143
7.	Firmagon (Degarelix) Intermittent Therapy Phase: Phase IV Type: Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: CURC - FIT-0002, NCT01512472
8.	The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 4-2007-0344, NCT01547416
9.	The Use of Thermal Suits as Preventing Hypothermia During Surgery Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: R12038, NCT01571544
10.	Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer Phase: Phase IV Type: Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: R12-3104L, NCT01581749
11.	Hydroxyethyl Starch and Renal Function After Radical Prostatectomy Phase: Phase IV Type: Diagnostic, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ASK-2-2011, NCT01486563
12.	Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer Phase: Phase IV Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CABAZ_L_06003, U1111-1123-9025, NCT01649635
13.	A Study of the Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Laparoscopic Prostatectomy Phase: Phase IV Type: Supportive care Status: Active Age: 30 to 90 Sponsor: Other Protocol IDs: UPCC 15810, NCT01661166
14.	GP Extended Action Triptorelin Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A-97-52014-181, 2011-004213-16, NCT01673984
15.	Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR100856, 212082PCR4003, NCT01692483
16.	A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A-38-52014-194, NCT01753297
17.	Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: KEK-ZH-NR:2010-0004/0, NCT01770340
18.	VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VESI-12J03, NCT01777217
19.	Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CSOM230B2412, NCT01794793
20.	STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial Phase: Phase III, Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000455008, MRC-STAMPEDE, EU-205102, MRC-PR08, ISRCTN78818544, EUDRACT-2004-000193-31, NCT00268476
21.	Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 to 75 Sponsor: NCI Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
22.	Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: MG2009_01, NCT01006395
23.	External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: GU004-11, NCT01603420
24.	FACBC Outcomes for Post Prostatectomy Phase: Phase III, Phase II Type: Diagnostic Status: Active Age: 18 to 95 Sponsor: Other Protocol IDs: 1R01CA169188-01, NCT01666808
25.	Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: RRK4368, 2012-002552-16, NCT01668459